RECURRENT OR PERSISTENT ENDOMETRIAL CARCINOMA

Clinical trials for RECURRENT OR PERSISTENT ENDOMETRIAL CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT OR PERSISTENT ENDOMETRIAL CARCINOMA trials appear

Sign up with your email to follow new studies for RECURRENT OR PERSISTENT ENDOMETRIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New hope for recurrent endometrial cancer: targeted combo trial opens

Disease control Recruiting now

This study is for people with endometrial cancer that has come back or persists after prior treatment. It tests combinations of targeted drugs and an immunotherapy drug called atezolizumab. The goal is to see if these treatments can shrink tumors or stop the cancer from growing f…

Matched conditions: RECURRENT OR PERSISTENT ENDOMETRIAL CARCINOMA

Phase: PHASE1, PHASE2 • Sponsor: Alliance Foundation Trials, LLC. • Aim: Disease control

Last updated Jun 16, 2026 12:54 UTC

RECURRENT OR PERSISTENT ENDOMETRIAL CARCINOMA

Get alerted when new RECURRENT OR PERSISTENT ENDOMETRIAL CARCINOMA trials appear

New hope for recurrent endometrial cancer: targeted combo trial opens